BAMCO Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.98M | Sell |
6,000
-1,500
| -20% | -$665K | ﹤0.01% | 270 |
|
|
2026
Q1 | $3.35M | Buy |
7,500
+2,300
| +44% | +$1.07M | 0.01% | 263 |
|
|
2025
Q4 | $2.36M | Hold |
5,200
| – | – | 0.01% | 279 |
|
|
2025
Q3 | $2.04M | Sell |
5,200
-3,800
| -42% | -$1.59M | 0.01% | 280 |
|
|
2025
Q2 | $4.01M | Sell |
9,000
-3,000
| -25% | -$1.38M | 0.01% | 257 |
|
|
2025
Q1 | $5.82M | Sell |
12,000
-6,000
| -33% | -$2.8M | 0.02% | 254 |
|
|
2024
Q4 | $7.25M | Sell |
18,000
-5,000
| -22% | -$2.32M | 0.02% | 240 |
|
|
2024
Q3 | $10.7M | Hold |
23,000
| – | – | 0.03% | 234 |
|
|
2024
Q2 | $10.8M | Hold |
23,000
| – | – | 0.03% | 236 |
|
|
2024
Q1 | $9.61M | Hold |
23,000
| – | – | 0.03% | 246 |
|
|
2023
Q4 | $9.36M | Hold |
23,000
| – | – | 0.02% | 237 |
|
|
2023
Q3 | $8M | Hold |
23,000
| – | – | 0.02% | 243 |
|
|
2023
Q2 | $8.09M | Hold |
23,000
| – | – | 0.02% | 241 |
|
|
2023
Q1 | $7.25M | Hold |
23,000
| – | – | 0.02% | 243 |
|
|
2022
Q4 | $6.64M | Buy |
23,000
+6,400
| +39% | +$1.95M | 0.02% | 252 |
|
|
2022
Q3 | $4.81M | Hold |
16,600
| – | – | 0.02% | 272 |
|
|
2022
Q2 | $4.68M | Buy |
+16,600
| New | +$4.44M | 0.02% | 287 |
|
|
2021
Q2 | – | Sell |
-60,113
| Closed | -$12.9M | – | 422 |
|
|
2021
Q1 | $12.9M | Sell |
60,113
-76,256
| -56% | -$16.7M | 0.03% | 272 |
|
|
2020
Q4 | $32.2M | Buy |
136,369
+53,018
| +64% | +$12.2M | 0.08% | 179 |
|
|
2020
Q3 | $22.7M | Buy |
83,351
+3,431
| +4% | +$947K | 0.07% | 175 |
|
|
2020
Q2 | $23.2M | Buy |
79,920
+1,291
| +2% | +$350K | 0.08% | 160 |
|
|
2020
Q1 | $18.7M | Buy |
78,629
+6,066
| +8% | +$1.39M | 0.09% | 144 |
|
|
2019
Q4 | $15.9M | Sell |
72,563
-5,522
| -7% | -$1.12M | 0.06% | 181 |
|
|
2019
Q3 | $13.2M | Sell |
78,085
-1,378
| -2% | -$244K | 0.05% | 187 |
|
|
2019
Q2 | $14.6M | Sell |
79,463
-196
| -0.2% | -$34.3K | 0.06% | 195 |
|
|
2019
Q1 | $14.7M | Sell |
79,659
-7,248
| -8% | -$1.34M | 0.06% | 183 |
|
|
2018
Q4 | $14.4M | Buy |
86,907
+495
| +0.6% | +$85.8K | 0.07% | 180 |
|
|
2018
Q3 | $16.7M | Buy |
86,412
+2,660
| +3% | +$474K | 0.07% | 182 |
|
|
2018
Q2 | $14.2M | Buy |
83,752
+21,615
| +35% | +$3.35M | 0.06% | 190 |
|
|
2018
Q1 | $10.1M | Buy |
62,137
+18,766
| +43% | +$3.07M | 0.05% | 200 |
|
|
2017
Q4 | $6.5M | Buy |
43,371
+13,588
| +46% | +$2.01M | 0.03% | 217 |
|
|
2017
Q3 | $4.53M | Buy |
+29,783
| New | +$4.48M | 0.02% | 231 |
|
Other funds holding VRTX
BAMCO Inc's VRTX Position: Q2 2026 in Review
BAMCO Inc reduced its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2026, selling an estimated $665K and leaving 6,000 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #270.
BAMCO Inc first reported a position in VRTX in Q3 2017 and has held it in 32 quarters since. The position peaked at $32.2M in Q4 2020. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- BAMCO Inc held 6,000 shares of Vertex Pharmaceuticals worth $2.98M as of Q2 2026.
- BAMCO Inc sold 1,500 Vertex Pharmaceuticals shares in Q2 2026, an estimated $665K.
- Vertex Pharmaceuticals made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #270 holding.
- BAMCO Inc first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 32 quarters since.
- BAMCO Inc's Vertex Pharmaceuticals position peaked at $32.2M in Q4 2020.
- 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.